2-238277281-T-G
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_022817.3(PER2):c.231-88A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.124 in 882,020 control chromosomes in the GnomAD database, including 7,576 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_022817.3 intron
Scores
Clinical Significance
Conservation
Publications
- advanced sleep phase syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- advanced sleep phase syndrome 1Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_022817.3. You can select a different transcript below to see updated ACMG assignments.
Frequencies
GnomAD3 genomes AF: 0.110 AC: 16699AN: 152118Hom.: 1215 Cov.: 32 show subpopulations
GnomAD4 exome AF: 0.127 AC: 92511AN: 729784Hom.: 6361 AF XY: 0.122 AC XY: 47844AN XY: 390758 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.110 AC: 16705AN: 152236Hom.: 1215 Cov.: 32 AF XY: 0.110 AC XY: 8225AN XY: 74448 show subpopulations
Age Distribution
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.